Automated Oxygen Titration with Non-invasive Ventilation in Hypoxaemic Adults with Cardiorespiratory Disease: a Randomised Cross-over Trial

Overview

Journal BMJ Open Respir Res

Date 2024 Jun 19

PMID 38897612

Authors

Louis Kirton

Stacey Kung

Georgina Bird

Melissa Black

Ruth Semprini

Allie Eathorne

Mark Weatherall

Alex Semprini

Richard Beasley

Affiliations

Soon will be listed here.

Abstract

Background: Closed-loop oxygen control systems automatically adjust the fraction of inspired oxygen (FiO) to maintain oxygen saturation (SpO) within a predetermined target range. Their performance with low and high-flow oxygen therapies, but not with non-invasive ventilation, has been established. We compared the effect of automated oxygen on achieving and maintaining a target SpO range with nasal high flow (NHF), bilevel positive airway pressure (bilevel) and continuous positive airway pressure (CPAP), in stable hypoxaemic patients with chronic cardiorespiratory disease.

Methods: In this open-label, three-way cross-over trial, participants with resting hypoxaemia (n=12) received each of NHF, bilevel and CPAP treatments, in random order, with automated oxygen titrated for 10 min, followed by 36 min of standardised manual oxygen adjustments. The primary outcome was the time taken to reach target SpO range (92%-96%). Secondary outcomes included time spent within target range and physiological responses to automated and manual oxygen adjustments.

Results: Two participants were randomised to each of six possible treatment orders. During automated oxygen control (n=12), the mean (±SD) time to reach target range was 114.8 (±87.9), 56.6 (±47.7) and 67.3 (±61) seconds for NHF, bilevel and CPAP, respectively, mean difference 58.3 (95% CI 25.0 to 91.5; p=0.002) and 47.5 (95% CI 14.3 to 80.7; p=0.007) seconds for bilevel and CPAP versus NHF, respectively. Proportions of time spent within target range were 68.5% (±16.3), 65.6% (±28.7) and 74.7% (±22.6) for NHF, bilevel and CPAP, respectively.Manually increasing, then decreasing, the FiO resulted in similar increases and then decreases in SpO and transcutaneous carbon dioxide (PtCO) with NHF, bilevel and CPAP.

Conclusion: The target SpO range was achieved more quickly when automated oxygen control was initiated with bilevel and CPAP compared with NHF while time spent within the range across the three therapies was similar. Manually changing the FiO had similar effects on SpO and PtCO across each of the three therapies.

Trial Registration Number: ACTRN12622000433707.

References

Trottier M, Bouchard P, LHer E, Lellouche F . Automated Oxygen Titration During CPAP and Noninvasive Ventilation in Healthy Subjects With Induced Hypoxemia. Respir Care. 2023; 68(11):1553-1560. PMC: 10589107. DOI: 10.4187/respcare.09866. View

Crossley D, McGuire G, Barrow P, Houston P . Influence of inspired oxygen concentration on deadspace, respiratory drive, and PaCO2 in intubated patients with chronic obstructive pulmonary disease. Crit Care Med. 1997; 25(9):1522-6. DOI: 10.1097/00003246-199709000-00019. View

Hansen E, Hove J, Bech C, Jensen J, Kallemose T, Vestbo J . Automated oxygen control with O2matic during admission with exacerbation of COPD. Int J Chron Obstruct Pulmon Dis. 2018; 13:3997-4003. PMC: 6300382. DOI: 10.2147/COPD.S183762. View

Lellouche F, Bouchard P, Roberge M, Simard S, LHer E, Maltais F . Automated oxygen titration and weaning with FreeO2 in patients with acute exacerbation of COPD: a pilot randomized trial. Int J Chron Obstruct Pulmon Dis. 2016; 11:1983-90. PMC: 5003517. DOI: 10.2147/COPD.S112820. View

Groves N, Tobin A . High flow nasal oxygen generates positive airway pressure in adult volunteers. Aust Crit Care. 2007; 20(4):126-31. DOI: 10.1016/j.aucc.2007.08.001. View

LHer E, Jaber S, Verzilli D, Jacob C, Huiban B, Futier E . Automated closed-loop standard manual oxygen administration after major abdominal or thoracic surgery: an international multicentre randomised controlled study. Eur Respir J. 2020; 57(1). DOI: 10.1183/13993003.00182-2020. View

Parke R, Bloch A, McGuinness S . Effect of Very-High-Flow Nasal Therapy on Airway Pressure and End-Expiratory Lung Impedance in Healthy Volunteers. Respir Care. 2015; 60(10):1397-403. DOI: 10.4187/respcare.04028. View

Brochard L, Isabey D, Piquet J, Amaro P, Mancebo J, Messadi A . Reversal of acute exacerbations of chronic obstructive lung disease by inspiratory assistance with a face mask. N Engl J Med. 1990; 323(22):1523-30. DOI: 10.1056/NEJM199011293232204. View

Fraser J, Spooner A, Dunster K, Anstey C, Corley A . Nasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end-expiratory lung volumes: a randomised crossover trial. Thorax. 2016; 71(8):759-61. PMC: 4975837. DOI: 10.1136/thoraxjnl-2015-207962. View

10.

Lellouche F, LHer E . Automated oxygen flow titration to maintain constant oxygenation. Respir Care. 2012; 57(8):1254-62. DOI: 10.4187/respcare.01343. View

11.

McKinstry S, Singer J, Baarsma J, Weatherall M, Beasley R, Fingleton J . Nasal high-flow therapy compared with non-invasive ventilation in COPD patients with chronic respiratory failure: A randomized controlled cross-over trial. Respirology. 2019; 24(11):1081-1087. DOI: 10.1111/resp.13575. View

12.

Harper J, Semprini R, Kearns N, Hatter L, Bird G, Braithwaite I . Determination of oxygen saturation compared to a prescribed target range using continuous pulse oximetry in acutely unwell medical patients. BMC Pulm Med. 2021; 21(1):332. PMC: 8546386. DOI: 10.1186/s12890-021-01700-6. View

13.

Beasley R . 'Swimming between the flags' with oxygen therapy is getting closer to reality. Respirology. 2023; 28(10):960-961. DOI: 10.1111/resp.14570. View

14.

Graham B, Steenbruggen I, Miller M, Barjaktarevic I, Cooper B, Hall G . Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med. 2019; 200(8):e70-e88. PMC: 6794117. DOI: 10.1164/rccm.201908-1590ST. View

15.

Perrin K, Wijesinghe M, Healy B, Wadsworth K, Bowditch R, Bibby S . Randomised controlled trial of high concentration versus titrated oxygen therapy in severe exacerbations of asthma. Thorax. 2011; 66(11):937-41. DOI: 10.1136/thx.2010.155259. View

16.

Munshi L, Mancebo J, Brochard L . Noninvasive Respiratory Support for Adults with Acute Respiratory Failure. N Engl J Med. 2022; 387(18):1688-1698. DOI: 10.1056/NEJMra2204556. View

17.

LHer E, Dias P, Gouillou M, Riou A, Souquiere L, Paleiron N . Automatic manual oxygen administration in the emergency department. Eur Respir J. 2017; 50(1). DOI: 10.1183/13993003.02552-2016. View

18.

Aubier M, Murciano D, Fournier M, Milic-Emili J, Pariente R, Derenne J . Central respiratory drive in acute respiratory failure of patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1980; 122(2):191-9. DOI: 10.1164/arrd.1980.122.2.191. View

19.

Chu D, Kim L, Young P, Zamiri N, Almenawer S, Jaeschke R . Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis. Lancet. 2018; 391(10131):1693-1705. DOI: 10.1016/S0140-6736(18)30479-3. View

20.

Rice K, Schmidt M, Buan J, Lebahn F, Schwarzock T . AccuO2 oximetry-driven oxygen-conserving device versus fixed-dose oxygen devices in stable COPD patients. Respir Care. 2012; 56(12):1901-5. View